Achieve Life Sciences Statistics
NASDAQ: ACHVHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
7.15-0.09 (-1.24%)
Market open · Delayed 15 min · as of Oct 8, 10:50 AM ET
Achieve Life Sciences by the numbers
Achieve Life Sciences has a market capitalization of $737.2 million based on 103.10M shares outstanding. With trailing EPS of $-1.69, Achieve Life Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.6% below its 50-day average and 30.4% above its 200-day average.
Average daily trading volume is 1.44M shares, or about $10.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACHV valuation vs. peer median
| Metric | ACHV | Peer median | Difference |
|---|---|---|---|
| Market cap | $737.18M | $154.57M | +377% |
| Avg. volume | 1.44M | 232.06K | +520% |
Peer median across 8 companies: QDEL, TKNO, MYGN, NNNN, IMDX, ICCC, BMRA, VNRX.
Valuation
- Market cap
- $737.18M
- EPS (TTM)
- $-1.69
- Shares outstanding
- 103.10M
Price and trading
- Previous close
- 7.24
- Open
- 7.14
- Day range
- 7.05 – 7.29
- 52-week range
- 2.62 – 8.64
- 52-week change
- +118.07%
- Beta
- —
- Volume
- 169.11K
- Average volume
- 1.44M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 737.18M
- Forward Pe
- -10.96
- Eps
- -1.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.64
- Week52 Low
- 2.62
- Avg Volume
- 1.44M
- Shares Outstanding
- 103.10M
- Ma50
- 7.49
- Ma200
- 5.48
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -17.25%
- Pct From52w Low
- 172.90%